ATE327258T1 - Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung - Google Patents

Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung

Info

Publication number
ATE327258T1
ATE327258T1 AT96906907T AT96906907T ATE327258T1 AT E327258 T1 ATE327258 T1 AT E327258T1 AT 96906907 T AT96906907 T AT 96906907T AT 96906907 T AT96906907 T AT 96906907T AT E327258 T1 ATE327258 T1 AT E327258T1
Authority
AT
Austria
Prior art keywords
monoclonal antibody
producing
reacting specifically
antibody reacting
fas ligand
Prior art date
Application number
AT96906907T
Other languages
English (en)
Inventor
Nobuhiko Kayagaki
Hideo Yagita
Ko Okumura
Motomi Nakata
Original Assignee
Ko Okumura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ko Okumura filed Critical Ko Okumura
Application granted granted Critical
Publication of ATE327258T1 publication Critical patent/ATE327258T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96906907T 1995-03-20 1996-03-21 Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung ATE327258T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8742095 1995-03-20
JP30349295 1995-10-27

Publications (1)

Publication Number Publication Date
ATE327258T1 true ATE327258T1 (de) 2006-06-15

Family

ID=26428696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906907T ATE327258T1 (de) 1995-03-20 1996-03-21 Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung

Country Status (8)

Country Link
US (1) US6946255B1 (de)
EP (1) EP0872488B1 (de)
JP (1) JP3451092B2 (de)
AT (1) ATE327258T1 (de)
AU (1) AU716731B2 (de)
CA (1) CA2215905A1 (de)
DE (1) DE69636170T2 (de)
WO (1) WO1996029350A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ311174A (en) * 1995-06-30 1999-04-29 Mochida Pharm Co Ltd Anti-fas ligand antibody which suppresses fas ligand-induced apoptosis in cells and method of assaying a fas ligand using the anti-fas ligand antibody
US6114507A (en) * 1995-06-30 2000-09-05 Mochida Pharmaceutical Co., Ltd. Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
US6096312A (en) * 1995-06-30 2000-08-01 Mochida Pharmaceutical Co., Ltd. Agent for suppressing a reduction of CD4+ lymphocytes
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
CA2264968A1 (en) * 1996-09-02 1998-03-12 Ko Okumura Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
EP1151012A4 (de) * 1998-11-19 2003-01-08 Smithkline Beecham Corp Rhamm antagonistische antikörper
JP5253325B2 (ja) * 2002-09-04 2013-07-31 中外製薬株式会社 ＭＲＬ／ｌｐｒマウスを用いた抗体の作製
AU2002328429A1 (en) * 2002-09-04 2004-03-29 Chugai Seiyaku Kabushiki Kaisha CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
ES2880460T3 (es) 2006-03-09 2021-11-24 Aethlon Medical Inc Eliminación extracorpórea de partículas microvesiculares
US9309320B2 (en) 2006-12-28 2016-04-12 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
KR20100130584A (ko) * 2007-12-12 2010-12-13 핀셀 에스알엘 항 Ｆａｓ 리간드 항체를 함유한 천포창 치료제
US20110189194A1 (en) * 2008-07-14 2011-08-04 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Use of cd95 inhibitors for the treatment of inflammatory disorders
EP2166358A1 (de) * 2008-09-17 2010-03-24 Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron Differentialdiagnostisches Biomarker von einen Schlaganfall imitierenden Bedingungen und Verfahren zur Verwendung dieser
AU2009326978B2 (en) 2008-12-12 2013-09-12 Pincell Srl Remedies for pemphigus containing anti Fas ligand antibodies
EP3076179A1 (de) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnose und behandlung von minderwertigen glioma
AU2016325482B2 (en) * 2015-09-23 2020-09-03 Apogenix Ag Anti-CD95L antibody
CN113402601A (zh) * 2021-06-09 2021-09-17 河南中泽生物工程有限公司 一种抗非洲猪瘟病毒p54蛋白单克隆抗体的制备方法及应用
CN118475613A (zh) 2021-12-01 2024-08-09 Inserm(法国国家健康医学研究院) 中和抗cd95l单克隆抗体
JP2025514847A (ja) 2022-04-26 2025-05-09 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Ｆａｓ軸拮抗薬及びＴｒｅｇ細胞枯渇剤拮抗薬を含む癌の治療のための併用療法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950588A (en) * 1985-07-10 1990-08-21 Molecular Diagnostics, Inc. Prolonged enhanced chemiluminescence
JPH08127594A (ja) * 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
ATE387458T1 (de) 1994-01-07 2008-03-15 Mochida Pharm Co Ltd Fas-antigenbindender ligand
DE4447484C2 (de) * 1994-04-08 1997-07-17 Deutsches Krebsforsch Mittel zur Hemmung von Apoptose

Also Published As

Publication number Publication date
AU716731B2 (en) 2000-03-02
CA2215905A1 (en) 1996-09-26
DE69636170T2 (de) 2006-11-02
EP0872488A4 (de) 1999-05-19
US6946255B1 (en) 2005-09-20
WO1996029350A1 (en) 1996-09-26
JP3451092B2 (ja) 2003-09-29
AU5014196A (en) 1996-10-08
EP0872488A1 (de) 1998-10-21
DE69636170D1 (de) 2006-06-29
EP0872488B1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
DE69636170D1 (de) Monoklonaler antikörper, der spezifisch mit dem fas-liganden reagiert, und verfahren zu seiner herstellung
DE3788058D1 (de) Zelltoxischer antikörperkomplex und verfahren zu seiner herstellung.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
SE8006424L (sv) Sett att bestemma ett antigen i losning
BR8003501A (pt) Aperfeicoamento no processo de determinacao de um antigeno, anticorpo ou complexo ou conjugado de antigeno-anticorpo, e um conjunto de reagentes para determinacao de reacao de aglutinacao imunoquimica
NZ329314A (en) Hybridoma & method of preparing a monoclonal antibody reactive with hc gp-39, use & treatment of rheumatoid arthritis
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
DE3485054D1 (de) Candida albicans zytoplasmaantigen, monoklonale antikoerper dagegen und verfahren zur herstellung.
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
EP0171083A3 (en) Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
EP1059533A4 (de) Methode zum immunologischen nachweis des anti-hm1.24 antikörpers
EP0057236A4 (de) Verfahren zum feststellen der tumorgebundenen glukoseseitenkette, verfahren zur diagnose von tumoren sowie "kit" dazu.
EP0613899A3 (de) Kokainderivat, sein Proteinkonjugat, monoklonale Antikörper produzierende Zellinie, Verfahren zur Herstellung der Zellinie und monoklonale Antikörper.
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
EP0922761A4 (de) Monoklonaler antikörper, spezifisch für anti-humanes fibrinmonomer, verfahren zur herstellung desselben, hybrydomzellen und ein immunoassay-verfahren
AU656198B2 (en) Diagnostic method
AR243932A1 (es) Hibridoma, procedimiento para la preparacion, anticuerpo monoclonal, procedimiento para su preparacion y composicion para diagnostico de base a dicho anticuerpo.
NO873154D0 (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
FR2710068B1 (fr) Dérivés de nucléosides, procédés de fabrication de ces dérivés de nucléosides et anticorps polyclonaux et monoclonaux spécifiques de ces dérivés.
JPS5347517A (en) Immobilized antibody membrane for antigen protein determinationmethod and its apparatus
IE881377L (en) Method for the quantitative determination of serum proteins¹in body fluids and agents for carrying out the process
SE9502765L (sv) Analysförfarande
DE58904518D1 (de) Verfahren zur bildlichen darstellung von tumoren unter verwendung von monoklonalen antikoerpern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties